{"id":66966,"date":"2026-05-12T16:02:42","date_gmt":"2026-05-12T10:32:42","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=66966"},"modified":"2026-05-12T16:02:45","modified_gmt":"2026-05-12T10:32:45","slug":"role-of-exercise-testing-in-non-ischemic-heart-disease","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/","title":{"rendered":"Role of Exercise Testing in Non-Ischemic Heart Disease"},"content":{"rendered":"<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/zgBDIt3xAAA?si=n_yjpn_yt5lLntGC\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n<p class=\"wp-block-paragraph\">In the management of non-ischemic heart disease, exercise testing has evolved from a tool for &#8220;ischemia detection&#8221; to a sophisticated method for <strong>functional phenotyping<\/strong>, <strong>hemodynamic unmasking<\/strong>, and <strong>prognostic stratification<\/strong>. For a clinician, the utility shifts towards evaluating the heart&#8217;s integrated response to metabolic demand.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">1. Hypertrophic Cardiomyopathy (HCM)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In HCM, exercise testing\u2014particularly <strong>Cardiopulmonary Exercise Testing (CPET)<\/strong>\u2014is essential for identifying patients at risk of heart failure (HF) progression rather than just sudden cardiac death (SCD).<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Prognostic Thresholds:<\/strong> A peak oxygen consumption (pVO<sub>2<\/sub>) of &lt;14 mL\/kg\/min or &lt;80% of predicted is a robust predictor of adverse outcomes, including HF hospitalization and the need for transplant.<\/li>\n\n\n\n<li class=\"\"><strong>Hemodynamic Unmasking:<\/strong> Exercise stress echocardiography (ESE) is used to detect <strong>latent Left Ventricular Outflow Tract (LVOT) obstruction<\/strong>. A gradient \u2265 50 mmHg during or immediately after exercise is clinically significant in symptomatic patients with resting gradients &lt;30 mmHg.<\/li>\n\n\n\n<li class=\"\"><strong>SCD Risk Stratification:<\/strong> The presence of <strong>Abnormal Blood Pressure Response (ABPR)<\/strong>\u2014defined as a failure to increase systolic BP by \u2265 20 mmHg or a drop in BP during exercise\u2014remains a traditional risk marker, though its specificity is limited in older cohorts.<\/li>\n\n\n\n<li class=\"\"><strong>Safety:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC13087641\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC13087641\/\">Recent large-scale data<\/a> (n=7637) confirms that CPET is safe in HCM; sustained ventricular arrhythmias (VA) occur in &lt;2% of cases, even in high-risk patients.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">2. Valvular Heart Disease<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The <a href=\"https:\/\/academic.oup.com\/eurheartj\/article\/46\/44\/4635\/8234488\" type=\"link\" id=\"https:\/\/academic.oup.com\/eurheartj\/article\/46\/44\/4635\/8234488\"><strong>2025 ESC\/EACTS Guidelines<\/strong> <\/a>have refined the role of stress testing in &#8220;asymptomatic&#8221; severe valvular disease to prevent irreversible ventricular damage.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Condition<\/strong><\/td><td><strong>Role of Exercise Testing<\/strong><\/td><td><strong>Key Triggers for Intervention<\/strong><\/td><\/tr><\/thead><tbody><tr><td><strong>Aortic Stenosis (AS)<\/strong><\/td><td>Unmask &#8220;pseudo-asymptomatic&#8221; status.<\/td><td>Symptoms during test or drop in BP below baseline.<\/td><\/tr><tr><td><strong>Mitral Regurgitation (MR)<\/strong><\/td><td>Unmask dynamic MR and exercise-induced pulmonary hypertension. Evaluate functional reserve in borderline LV function.<\/td><td>Exercise-induced PASP &gt; 60 mmHg or unmasking of symptoms. LVESDi \u2265 20 mm\/m<sup>2<\/sup> or failure of EF to increase.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">3. HFpEF and Infiltrative Diseases<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Exercise testing is often the only way to diagnose <strong>HFpEF<\/strong> when resting hemodynamics are normal.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>The &#8220;Gold Standard&#8221;:<\/strong> Invasive CPET (combining gas exchange with right heart catheterization) remains the definitive method to demonstrate exercise-induced elevation in <strong>Pulmonary Capillary Wedge Pressure (PCWP)<\/strong> (>25 mmHg).<\/li>\n\n\n\n<li class=\"\"><strong>Non-Invasive Markers:<\/strong> A high VE\/VCO<sub>2<\/sub> slope (<a href=\"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3470\" type=\"link\" id=\"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3470\">ventilatory efficiency<\/a>) is often a more sensitive predictor of mortality in HFpEF than pVO<sub>2<\/sub> itself. VCO<sub>2<\/sub>: carbon dioxide production; VE minute ventilation.<\/li>\n\n\n\n<li class=\"\"><strong>Cardiac Amyloidosis (ATTR-CA):<\/strong> Patients typically exhibit a significantly lower pVO<sub>2<\/sub> and a <a href=\"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3470\" type=\"link\" id=\"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3470\">&#8220;decoupling&#8221; of the TAPSE\/PASP ratio during effort<\/a>, reflecting limited right ventricular contractile reserve compared to other hypertrophic phenotypes. PASP Pulmonary Artery Systolic Pressure.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">4. Inherited Arrhythmias (ARVC &amp; CPVT)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In these conditions, exercise testing is primarily diagnostic and for risk assessment of effort-induced VAs.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>ARVC:<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4521905\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4521905\/\">Exercise testing is recommended every 1\u20132 years<\/a> to monitor for effort-induced VAs, which typically present with a <strong>Left Bundle Branch Block (LBBB)<\/strong> morphology. High-intensity exercise is strictly restricted as it accelerates desmosomal disruption and disease progression.<\/li>\n\n\n\n<li class=\"\"><strong>Catecholaminergic Polymorphic VT (CPVT):<\/strong> Exercise testing is the diagnostic cornerstone, revealing progressive ventricular ectopy (starting with isolated PVCs and moving to bidirectional or polymorphic VT) as the heart rate increases toward a specific threshold.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">5. Summary of Key Parameters for Clinical Practice<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Peak VO<sub>2<\/sub> (the highest rate of oxygen consumption<\/strong>)<strong>:<\/strong> The most objective measure of functional capacity.<\/li>\n\n\n\n<li class=\"\"><strong><a href=\"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.107.686576\" type=\"link\" id=\"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.107.686576\">VE\/VCO<sub>2<\/sub> Slope<\/a>:<\/strong> Values 36 and above indicate ventilatory class III and above. Heart transplantation or Left Ventricular Assist Device implantation should be considered for subjects in VC-III and VC-IV who do not improve to a lower class after optimization of pharmacological interventions, implementation of an aerobic training program, and consideration of cardiac resynchronization therapy.<\/li>\n\n\n\n<li class=\"\"><strong><a href=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/cir.0b013e3181e52e69\" type=\"link\" id=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/cir.0b013e3181e52e69\">Oxygen Pulse (VO<sub>2<\/sub>\/HR)<\/a>:<\/strong> A surrogate for stroke volume; a plateau or decline during exercise suggests contractile failure or severe valvular\/obstructive issues.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n","protected":false},"excerpt":{"rendered":"<p>In the management of non-ischemic heart disease, exercise testing has evolved from a tool for &#8220;ischemia detection&#8221; to a sophisticated method for functional phenotyping, hemodynamic unmasking, and prognostic stratification. For a clinician, the utility shifts towards evaluating the heart&#8217;s integrated response to metabolic demand. 1. Hypertrophic Cardiomyopathy (HCM) In HCM, exercise testing\u2014particularly Cardiopulmonary Exercise Testing [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":66968,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-66966","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Role of Exercise Testing in Non-Ischemic Heart Disease - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Role of Exercise Testing in Non-Ischemic Heart Disease - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"In the management of non-ischemic heart disease, exercise testing has evolved from a tool for &#8220;ischemia detection&#8221; to a sophisticated method for functional phenotyping, hemodynamic unmasking, and prognostic stratification. For a clinician, the utility shifts towards evaluating the heart&#8217;s integrated response to metabolic demand. 1. Hypertrophic Cardiomyopathy (HCM) In HCM, exercise testing\u2014particularly Cardiopulmonary Exercise Testing [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-12T10:32:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-12T10:32:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1203\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Role of Exercise Testing in Non-Ischemic Heart Disease\",\"datePublished\":\"2026-05-12T10:32:42+00:00\",\"dateModified\":\"2026-05-12T10:32:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/\"},\"wordCount\":599,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/\",\"name\":\"Role of Exercise Testing in Non-Ischemic Heart Disease - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg\",\"datePublished\":\"2026-05-12T10:32:42+00:00\",\"dateModified\":\"2026-05-12T10:32:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg\",\"width\":1203,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/role-of-exercise-testing-in-non-ischemic-heart-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Role of Exercise Testing in Non-Ischemic Heart Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Role of Exercise Testing in Non-Ischemic Heart Disease - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/","og_locale":"en_US","og_type":"article","og_title":"Role of Exercise Testing in Non-Ischemic Heart Disease - All About Cardiovascular System and Disorders","og_description":"In the management of non-ischemic heart disease, exercise testing has evolved from a tool for &#8220;ischemia detection&#8221; to a sophisticated method for functional phenotyping, hemodynamic unmasking, and prognostic stratification. For a clinician, the utility shifts towards evaluating the heart&#8217;s integrated response to metabolic demand. 1. Hypertrophic Cardiomyopathy (HCM) In HCM, exercise testing\u2014particularly Cardiopulmonary Exercise Testing [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-05-12T10:32:42+00:00","article_modified_time":"2026-05-12T10:32:45+00:00","og_image":[{"width":1203,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Role of Exercise Testing in Non-Ischemic Heart Disease","datePublished":"2026-05-12T10:32:42+00:00","dateModified":"2026-05-12T10:32:45+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/"},"wordCount":599,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/","url":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/","name":"Role of Exercise Testing in Non-Ischemic Heart Disease - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg","datePublished":"2026-05-12T10:32:42+00:00","dateModified":"2026-05-12T10:32:45+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Role-of-Exercise-Testing-in-Non-Ischemic-Heart-Disease.jpg","width":1203,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/role-of-exercise-testing-in-non-ischemic-heart-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Role of Exercise Testing in Non-Ischemic Heart Disease"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=66966"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66966\/revisions"}],"predecessor-version":[{"id":66982,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66966\/revisions\/66982"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/66968"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=66966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=66966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=66966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}